Omeros Corp.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 5.15%58.400.0%$1738.44m
GILDGilead Sciences, Inc. -0.49%74.951.0%$1311.94m
REGNRegeneron Pharmaceuticals, Inc. 0.54%581.352.5%$966.57m
AMGNAmgen, Inc. -0.34%223.371.3%$644.14m
NVAXNovavax, Inc. 0.36%45.00102.0%$581.79m
VRTXVertex Pharmaceuticals, Inc. 0.15%277.801.9%$545.53m
BIIBBiogen, Inc. -0.26%299.731.6%$409.34m
ILMNIllumina, Inc. -1.92%365.843.5%$381.70m
SRNESorrento Therapeutics, Inc. -0.07%4.951.8%$297.70m
ALXNAlexion Pharmaceuticals, Inc. 0.98%115.542.0%$267.65m
SGENSeattle Genetics, Inc. -0.16%151.316.1%$254.10m
AAgilent Technologies, Inc. 0.58%87.191.6%$200.66m
BMRNBioMarin Pharmaceutical, Inc. -1.40%104.124.3%$177.26m
CODXCo-Diagnostics, Inc. -1.00%17.300.0%$169.20m
INCYIncyte Corp. -0.36%100.192.5%$156.93m

Company Profile

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.